With A Vitamin Type Active Ingredient Patents (Class 514/168)
-
Patent number: 5883086Abstract: The present invention relates to a nutritional supplement (10) containing from 5% to 2000% each of the RDA of vitamins (18) A (22), C (26), D (28), E (30) and .beta.-carotene (24), from 5% to 500% of the RDA of the minerals (20) selenium (32), zinc (34), magnesium (36), calcium (38), iodine (40) and potassium (42), from 5 to 100 mg dehydroepiandrosterone (DHEA) (12), from 0.1 to 10 mg trans-ferulic acid (14), and one or more plant extracts (16) selected from ginseng (46) and garlic (44). These DHEA-containing nutritional supplements are useful in the alleviation of an irregular heartbeat as well as the general symptoms of stress.Type: GrantFiled: May 2, 1997Date of Patent: March 16, 1999Inventor: John C. Craft
-
Patent number: 5880116Abstract: The present invention provides a method for treating patients with Alzheimer's Disease which comprises administering a an effective amount of a celastrol formulation to the patients. One source of raw material for such a celastrol formulation is the root of the vine tripterygium wilfordii Hook F.Type: GrantFiled: December 13, 1996Date of Patent: March 9, 1999Assignee: Neurocal InternationalInventor: Carmen Vigo-Pelfrey
-
Patent number: 5877296Abstract: This invention describes carrier-drug conjugates prepared from disulfide analogs of the calicheamicin family of potent antitumor antibiotics and their derivatives, as well as similar analogs from related antitumor antibiotics such as the esperamicins. The carrier can be an antibody, growth factor, or steroid which targets an undesired population of cells, such as those of a tumor. Whole protein carriers as well as their antigen-recognizing fragments and their chemically or genetically manipulated counterparts are useful for the targeting portion of the conjugates. This invention includes compounds required for the synthesis of these conjugates, appropriate pharmaceutical compositions of the carrier-drug conjugates, and their method of use.Type: GrantFiled: May 26, 1995Date of Patent: March 2, 1999Assignee: American Cyanamid CompanyInventors: Philip Ross Hamann, Lois Hinman, Irwin Hollander, Ryan Holcomb, William Hallett, Hwei-Ru Tsou, Martin J. Weiss
-
Patent number: 5807586Abstract: The present invention relates to a method of supplementing the dietary needs of women whereby an effective amount of a life stage appropriate dietary supplement is administered to a woman at each of her life stages throughout her life.Type: GrantFiled: July 30, 1996Date of Patent: September 15, 1998Assignee: Energetics, Inc.Inventors: Sherry D. Jackson, Jeffrey B. Blumberg
-
Patent number: 5804573Abstract: Pharmaceutically active derivatives of vitamin D.sub.2 and vitamin D.sub.3 in a solid state composition are stabilized by the presence of effective amounts of pharmaceutically acceptable antioxidant and polyoxyalkyl stabilizer. Specified antioxidants are butylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA), vitamin E, propyl gallate, .beta.-carotene and ascorbic acid, while specified stabilizers are polyethyleneglycols, polyethyleneglycol ethers, polyethyleneglycol esters, polyoxyethylated castor oil, polyoxyethylated hydrogenated castor oil, polyoxyethylated sorbitan fatty acid esters and polyoxyethylated glycerol fatty acid esters. Suitable proportions of these ingredients by weight lie within the ranges 0.00003 to 0.8 vitamin D.sub.2 or D.sub.3 derivative: 0.01 to 0.1 antioxidant: 0.03 to 30 polyoxyalkyl stabilizer. Compared with similar non-stabilized compositions, the inventive compositions are particularly stable at elevated temperatures and/or humidities.Type: GrantFiled: May 31, 1996Date of Patent: September 8, 1998Assignee: Teva Pharmaceutical Industries Ltd.Inventor: David Isaac Silver
-
Patent number: 5786384Abstract: The present invention relates to a method for the treatment and protection of human and animal skin which contains vitamin E in a high dose and, in addition, may optionally further contain vitamin C, vitamin A, vitamins of the B series, blood circulation-promoting agents and/or vasodilators, phospholipids, unsaturated fatty acids and/or emulsifiers.Type: GrantFiled: March 18, 1997Date of Patent: July 28, 1998Inventor: Roshdy Ismail
-
Patent number: 5780451Abstract: An enteral nutritional product for a person having ulcerative colitis contains in combination (a) an oil blend which contains eicosapentaenoic acid (20:5n3) and/or docosahexaenoic acid (22:6n3), and (b) a source of indigestible carbohydrate which is metabolized to short chain fatty acids by microorganisms present in the human colon. Preferably the nutritional product also contains one or more nutrients which act as antioxidants.Type: GrantFiled: April 1, 1994Date of Patent: July 14, 1998Assignee: Abbott LaboratoriesInventors: Stephen Joseph DeMichele, Keith Allen Garleb, John William McEwen, Martha Kay Fuller
-
Patent number: 5770233Abstract: An object of the present invention is to provide an infusion preparation set (a container filled with infusion liquids) useful for preparation of an infusion liquid containing sugars, amino acids, electrolytes, a fat emulsion and vitamins. The present invention is constituted by the use of a container having two compartments which are separated from each other by a separation means, which contains an infusion liquid comprising a fat emulsion, sugars, fat-soluble vitamins and specified water-soluble vitamins in the first compartment and an infusion liquid comprising amino acids, electrolytes and other specified water-soluble vitamins in the second compartment. An infusion preparation containing sugars, amino acids, electrolytes, a fat emulsion and vitamins can be obtained easily and aseptically upon use, by simply removing a separation means and mixing the infusion liquids included in the first and second compartments.Type: GrantFiled: April 21, 1995Date of Patent: June 23, 1998Assignee: The Green Cross CorporationInventors: Takae Kido, Shigeo Ii, Shun-ichi Abe, Kazumasa Yokoyama
-
Patent number: 5767091Abstract: The present invention provides an analgesic effect enhancing preparation capable of enhancement of the effect of analgesics, the preparation comprising as an active ingredient the following amino acid composition (%); leucine 8.0-16.0, isoleucine 4.0-9.0, valine 4.0-9.0, lysine 6.0-13.0, threonine 3.0-6.0, tryptophan 1.0-2.0, methionine 2.0-5.0, cysteine 0.5-2.0, phenylalanine 3.0-7.0, tyrosine 0.2-1.0, histidine 2.0-5.0, arginine 30.0-60.0, alanine 0.5-2.0, aminoacetic acid 0.5-2.0, serine 0.2-1.0, proline 0.5-2.0, aspartic acid 0.1-0.5 and glutamic acid 0.1-0.5, calculated as free amino acids.The analgesic effect enhancing preparation of the present invention potentiates analgesic effect of various analgesics.Type: GrantFiled: August 20, 1996Date of Patent: June 16, 1998Assignee: Otsuka Pharmaceutical Factory, Inc.Inventors: Kiyoshi Mukai, Hideaki Kohri
-
Patent number: 5763429Abstract: The invention provides therapeutic methods for inhibiting, ameliorating or alleviating the hyperproliferative cellular activity of diseases of the prostate, e.g., prostatic cancer and prostatic hyperplasia, which includes administering to a patient in need thereof an active vitamin D analogue. Cell differentiation is promoted, induced or enhanced without causing to the patient dose-limiting hypercalcemia and hypercalciuria.Type: GrantFiled: December 30, 1996Date of Patent: June 9, 1998Assignee: Bone Care International, Inc.Inventors: Charles W. Bishop, Joyce C. Knutson, Richard B. Mazess
-
Patent number: 5750496Abstract: A method for controlling infections caused by Cryptosporidium parvum. The method comprises using protease inhibiting compounds, preferably serine protease inhibitors, to inhibit excystation, invasion, and parasite maturation and development. The method is directed to therapeutic treatment of mammals, such as humans, exposed to C. parvum, and additionally as a prophylactic treatment in immunocompromised subjects at high risk for contracting cryptosporidiosis.Type: GrantFiled: August 12, 1996Date of Patent: May 12, 1998Assignee: Utah State UniversityInventors: John R. Forney, Shiguang Yang, Mark C. Healey
-
Patent number: 5733902Abstract: Agents, containing at least one compound having antiprogestational activity and at least one compound having anti-estrogenic activity, are suitable for the treatment of hormone-dependent tumors.Type: GrantFiled: February 14, 1994Date of Patent: March 31, 1998Assignee: Schering AktiengesellschaftInventor: Martin Schneider
-
Patent number: 5719134Abstract: A dietary composition comprising, based on total caloric content of the composition,a) a carbohydrate component which comprises from 50 to 65% of the total caloric content;b) a lipid component which comprises from 20 to 35% of the total caloric content; andc) an amino acid component which comprises from 10 to 20% of the total caloric content and which comprises specified amino acids and amounts thereof is useful providing nutrition to human adolescents.Type: GrantFiled: September 17, 1996Date of Patent: February 17, 1998Assignee: Novartis Nutrition AGInventors: Mary K. Schmidl, Carol J. Lowry
-
Patent number: 5719133Abstract: A dietary composition comprising, based on total caloric content of the composition,a) a carbohydrate component which comprises from 50 to 65% of the total caloric content;b) a lipid component which comprises from 20 to 35% of the total caloric content; andc) an amino acid component which comprises from 10 to 20% of the total caloric content and which comprises specified amino acids and amounts thereof is useful providing nutrition to human adolescents.Type: GrantFiled: September 21, 1994Date of Patent: February 17, 1998Assignee: Novartis Nutrition AGInventors: Mary K. Schmidl, Carol J. Lowry
-
Patent number: 5703041Abstract: A composition for topical application is provided which contains at least one water-sensitive active agent with a topical action and at least one polyol, the latter being present in a quantity which is effective for obtaining a water activity value of the composition of less than or equal to 0.85 with the aim of stabilizing the water-sensitive active agent, the composition containing at least one structuring agent chosen from polymers and oils. The water-sensitive active agent can, in particular, be an enzyme. The composition obtained can be used for cleansing and/or caring for and/or protecting the skin and/or keratinous fibers.Type: GrantFiled: July 24, 1996Date of Patent: December 30, 1997Assignee: L'OrealInventors: Isabelle Afriat, Didier Gagnebien
-
Patent number: 5696103Abstract: A method for treating osteoporosis via administration of a compound of the formula, 1.alpha.-fluoro-25-hydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, in an amount therapeutically effective to restore bone density to an asymptomatic level, without inducing hypercalciuria, hypercalcemia, or nephrotoxicity is provided.Type: GrantFiled: November 17, 1995Date of Patent: December 9, 1997Assignees: Syntex (U.S.A.) Inc., Hoffmann-La Roche Inc.Inventors: John Joseph Nestor, Jr., Brian Henry Vickery, Milan Radoje Uskokovic
-
Patent number: 5696114Abstract: The invention refers to the treatment and prevention of eosinophil-mediated diseases with paf antagonists and a procedure for determining their efficacy. According to the invention for treating and prevention a disease mediated by eosinophils a combination with an effective amount of at least one paf antagonist is administered to a subject requiring said treatment of allergy and inflammation, wherein the paf antagonist is a hydrophilic or non-hydrophilic triazolothieno-diazepine or a homologue thereof, a ginkgolide, a ginkgolide mixture or a synthetic ginkgolide derivate, or an analogue of the paf or a mixture with/of these compounds.Type: GrantFiled: May 19, 1994Date of Patent: December 9, 1997Inventor: Ruth Korth
-
Patent number: 5681578Abstract: A composition for relieving stress, anxiety, grief, and depression includes GABA (gamma amino butyric acid), glutamine, glycine, magnesium, passion flower, primula officinalis, and vitamin B-6.Type: GrantFiled: January 22, 1996Date of Patent: October 28, 1997Inventor: Billie J. Sahley
-
Patent number: 5668183Abstract: Novel, stable, cold water-dispersible preparations of fat-soluble substances contain a water-soluble or water-dispersible lignin derivative as the matrix component. These preparations are manufactured by preparing an aqueous emulsion of the fat-soluble substance(s) and the water-soluble or water-dispersible lignin derivative and, if desired, converting this emulsion into a dry powder. The preparations in accordance with the invention can be used not only for animal nutrition but also for human nutrition.Type: GrantFiled: August 8, 1996Date of Patent: September 16, 1997Assignee: Roche Vitamins Inc.Inventor: Bruno Leuenberger
-
Patent number: 5654011Abstract: The present invention relates to dietary supplements for supplementing the dietary needs of women and preventing or reducing life stage associated health risks during each of their principal adult life stages (pre-perimenopause, perimenopause and menopause, or post-menopause).Type: GrantFiled: July 30, 1996Date of Patent: August 5, 1997Assignee: Energetics, Inc.Inventors: Sherry D. Jackson, Jeffrey B. Blumberg
-
Patent number: 5654292Abstract: Compositions containing vitamin D compounds in a suitable carrier and methods employing such compositions are disclosed for cosmetic uses in the treatment of various skin conditions such as lack of adequate skin firmness, wrinkles, lack of dermal hydration and insufficient sebum secretion. Various formulations of the compositions including creams, lotions and ointments are disclosed for use topically, orally or parenterally in accordance with this invention.Type: GrantFiled: June 7, 1995Date of Patent: August 5, 1997Assignee: Wisconsin Alumni Research FoundationInventors: Hector F. DeLuca, Connie M. Smith
-
Patent number: 5652261Abstract: The present invention relates to a method for the treatment and protection of human and animal skin which contains vitamin E in a high dose and, in addition, may optionally further contain vitamin C, vitamin A, vitamins of the B series, blood circulation-promoting agents and/or vasodilators, phospholipids, unsaturated fatty acids and/or emulsifiers.Type: GrantFiled: August 31, 1994Date of Patent: July 29, 1997Inventor: Roshdy Ismail
-
Patent number: 5641766Abstract: Alzheimer's disease and immune deficiency disorders may be effectively treated by administering a .DELTA.5-Androstene-3.beta.-ol-17-one having a C.sub.7 substituent selected from the group consisting of oxo, hydroxy and groups convertible thereto by hydrolysis by administering a therapeutic amount of a .DELTA.5-Androstene-3.beta.-ol-17-one having a C.sub.7 substituent selected from the group consisting of oxo, hydroxy and groups convertible thereto by hydrolysis.Type: GrantFiled: September 13, 1995Date of Patent: June 24, 1997Assignee: Humanetics CorporationInventor: Henry A. Lardy
-
Patent number: 5607921Abstract: A stabilized composition capable of releasing an active agent in contact with the skin, contains at least two precursors of this same active agent, capable of simultaneously releasing this active agent by at least two different specific enzymatic reactions in order to release a large amount of active agent at a faster rate than the sum of the rates of the first enzymatic reaction and of the second enzymatic reaction taken separately, the first precursor being chosen from active agent monosaccharide derivatives and active agent amides. The composition is useful for dermatological and/or cosmetic treatments applied topically.Type: GrantFiled: January 31, 1995Date of Patent: March 4, 1997Assignee: L'OrealInventors: Dominique Bernard, Quang Lan Nguyen
-
Patent number: 5599840Abstract: A nutritional composition, adapted for consumption by mammals, contains (1) an orally ingestible diluent or carrier, except an oily carrier or diluent which comprises C.sub.8-18 saturated fatty acids, oleic acid and derivatives of these acids, and (2) a composition of matter which consists of (a) from about 13.0 to about 27.5% by weight of at least one compound selected from linolenic acid and its salts, esters and amides, calculated as the free acid, and (b) about 87.0 to about 72.5% by weight of at least one compound selected from linoleic acid and its salts, esters and amides thereof, calculated as the free acid, the salts, esters and amides of linolenic and linoleic acid being both physiologically hydrolyzable and pharmacologically acceptable. The invention also relates to a method for treating a mammal for the purpose of inducing therein at least one physiological effect selected from memory enhancement and analgesia, by administration of an effective amount of the nutritional composition.Type: GrantFiled: November 13, 1995Date of Patent: February 4, 1997Assignee: Bar Ilan UniversityInventor: Shlomo Yehuda
-
Patent number: 5571802Abstract: A method of treating post menopausal osteoporosis which comprises administering to a subject having the disease an effective daily dose of 26,26,26,27,27,27-hexafluoro-1.alpha.,25-dihydroxycholecalciferol compound in an amount from about 0.05 .mu.g to about 2.0 .mu.g.Type: GrantFiled: February 18, 1994Date of Patent: November 5, 1996Assignee: Wisconsin Alumni Research FoundationInventors: Hector F. Deluca, Yosuke Ogura
-
Patent number: 5565442Abstract: The invention relates to a process for stabilizing pharmaceutically active derivatives of vitamin D2 and D3. At least one pharmaceutically active vitamin D derivative is dissolved in a solvent with an antioxidant. This solution is mixed with a pharmaceutically acceptable stabilizer and at least one solid pharmaceutical excipient or carrier which is present in an amount sufficient to impart the characteristics of a solid to the composition. Finally, the solvent is removed.Type: GrantFiled: September 13, 1993Date of Patent: October 15, 1996Assignee: Teva Pharmaceutical Industries Ltd.Inventor: David I. Silver
-
Patent number: 5540919Abstract: Disclosed is a method for enhancing the production of T cell lymphokines, which comprises exposing T cell lymphocytes which have a potential to make selected T cell lymphokines to an appropriate concentration of at least one particular steroid hormone prior to cellular activation. Also disclosed are applications of the method for clinically diagnosing abnormal interleukin production, maintaining in vitro tissue cultures of T cells, overcoming certain types of immunosuppression caused by elevated GCS levels, caused by endogenous production or exogenous administration, use as a vaccine adjuvant to selectively direct the vaccine-induced immune response down a protective, rather than a potentially pathologic or non-protective, immunologic pathway, as a treatment for naturally occuring aging-related decreases in immune function, as a treatment for stress or trauma-induced decreases in immune function, and as an agent to facilitate desensitization to agents to which a warm-blooded animal is allergic.Type: GrantFiled: February 16, 1993Date of Patent: July 30, 1996Assignee: University of Utah Research FoundationInventors: Raymond A. Daynes, Barbara A. Araneo
-
Patent number: 5541220Abstract: The present invention relates to a method for the treatment and protection of human and animal skin which contains vitamin E in a high dose and, in addition, may optionally further contain vitamin C, vitamin A, vitamins of the B series, blood circulation-promoting agents and/or vasodilators, phospholipids, unsaturated fatty acids and/or emulsifiers.Type: GrantFiled: April 29, 1992Date of Patent: July 30, 1996Inventor: Roshdy Ismail
-
Patent number: 5532229Abstract: A method of delivering a nutritional or therapeutic amount of vitamin D to the blood of a mammal, which method comprises topically administering to the skin of the mammal a vitamin D nutritionally or therapeutically-effective amount of a composition comprising a nutritional or therapeutically effective amount of vitamin D in a suitable pharmaceutically-acceptable carrier, diluent or adjuvant therefor and compositions therefor. The method provides a more suitable, safer and efficient way of providing a mammal with its daily vitamin D intake.Type: GrantFiled: May 3, 1994Date of Patent: July 2, 1996Inventor: Reinhold W. Vieth
-
Patent number: 5514672Abstract: Increase in the rate of hair growth, stimulation of hair follicles to produce new hair growth, prolongation of the anagen phase of the hair cycle, and conversion of vellus hair to growth as terminal hair, and treatment of alopecias due to organic dysfunction of the hair follicle is attained in mammalian skins by either oral administration or by topical application to the skin, hair and/or hair follicles of the mammal of effective amounts of a retinoid, particularly retinoic acid. The retinoid may be administered or applied alone or with other adjunctive compounds including vitamins, such as Vitamin D.sub.3, hormones, antiandrogens and/or vasodilators.Type: GrantFiled: December 13, 1988Date of Patent: May 7, 1996Inventor: Gail S. Bazzano
-
Patent number: 5512555Abstract: The instant invention involves methods of treating sweat related conditions with compounds that are 5.alpha.-reductase inhibitors. The 5.alpha.-reductase inhibitors may be administered alone or in combination with other active agents to treat conditions such as apocrine gland sweating, hyperhidrosis, and hydradenitis suppurativa.Type: GrantFiled: July 21, 1994Date of Patent: April 30, 1996Assignee: Merck & Co., Inc.Inventor: Joanne Waldstreicher
-
Patent number: 5508274Abstract: A pharmaceutical composition containing 24,25-dihydroxycholecalciferol is provided. The active ingredient used in the present invention is an intrinsic and safe substance, and so does not exhibit hypercalcemia which is the side effect induced by conventional antirachitic agents, and is effective for the treatment of rickets, particularly vitamin D resistant rickets.Type: GrantFiled: November 8, 1994Date of Patent: April 16, 1996Assignees: Kureha Chemical Industry Company, Ltd., Yoshiki SeinoInventors: Yoshiki Seino, Hiroyuki Tanaka, Yumiko Nagai
-
Patent number: 5496812Abstract: A topical preparation of between 1% and 3% hydrocortisone and 1.5% and 4.5% tolnaftate, by weight, in a 2:3 ratio used for treating a fungal infection of the skin. The specified ratio provides an accelerated and non-toxic treatment.Type: GrantFiled: October 7, 1994Date of Patent: March 5, 1996Inventor: Chris E. Platt
-
Patent number: 5478816Abstract: Liquid vitamin formulation containing an ester of antirachitic vitamin D esterified at the 3 carbon position such as vitamin D.sub.3 palmitate, greater than 252 mg/ml water and at least about 100 mg/ml polyhydroxylated solvent such as glycerine. The formulations have improved taste and improved storage stability.Type: GrantFiled: July 2, 1993Date of Patent: December 26, 1995Assignee: Bristol-Myers Squibb CompanyInventor: Mandar V. Shah
-
Patent number: 5468776Abstract: A composition of matter which consists of (a) from about 16.7 to about 22.2% by weight of at least one compound selected from the group consisting of linolenic acid and derivatives thereof, calculated as the free acid, said derivatives of linolenic acid being both physiologically hydrolyzable and pharmacologically acceptable, and (b) about 77.8 to about 83.3% by weight of at least one compound selected from the group consisting of linoleic acid and derivatives thereof, calculated as the free acid, said derivatives of linoleic acid being both physiologically hydrolyzable and pharmacologically acceptable, is utilized e.g. as a pharmaceutical formulation or nutritional composition, in absence of an oily carrier or diluent which comprises at least one member of the group consisting of C.sub.Type: GrantFiled: July 20, 1993Date of Patent: November 21, 1995Assignee: Bar Ilan UniversityInventor: Shlomo Yehuda
-
Patent number: 5431925Abstract: Disclosed is a nutritive composition for patients being treated with anticancer drugs, which comprises 1-5 mg weight % of a retinoid compound in the solid content of the composition composed of proteins, carbohydrates, fats, vitamins and minerals as major components. It can prevent the immunosuppression induced by the administration of anticancer drugs, and can prevent the infectious diseases arising from said immunosuppression and helps to enhance the therapeutic effect on the patients.Type: GrantFiled: January 24, 1994Date of Patent: July 11, 1995Assignee: Snow Brand Milk Products Co., Ltd.Inventors: Toshihiro Ohmori, Minoru Yanai
-
Patent number: 5416114Abstract: A composition of matter which consists of (a) from about 13.0 to about 27.5% by weight of at least one compound selected from the group consisting of linolenic acid and derivatives thereof, calculated as the free acid, said derivatives or linolenic acid being both physiologically hydrolyzable and pharmacologically acceptable, and (b) about 87.0 to about 72.5% by weight of at least one compound selected from the group consisting of linoleic acid and derivatives thereof, calculated as the free acid, said derivatives of linoleic acid being both physiologically hydrolyzable and pharmacologically acceptable, is utilized e.g. as a pharmaceutical formulation or nutritional composition, in absence of an oily carrier or diluent which comprises at least one member of the group consisting of C.sub.Type: GrantFiled: July 20, 1993Date of Patent: May 16, 1995Assignee: Bar Ilan UniversityInventor: Shlomo Yehuda
-
Patent number: 5403831Abstract: A method for reversing loss of bone mass or bone mineral content in a human being suffering from osteoporosis is disclosed which comprises administering to the human being a daily dosage of at least 2.0 micrograms/day of 1-alpha-hydroxy-Vitamin D.sub.2.Type: GrantFiled: September 10, 1993Date of Patent: April 4, 1995Assignee: Bone Care International, Inc.Inventors: Hector F. DeLuca, Charles W. Bishop, Richard B. Mazess, John C. Gallagher
-
Patent number: 5395830Abstract: A method of treating osteoporosis comprising the administration of an effective amount of 1.alpha.,24(R)-dihydroxy-22(E)-dehydro-vitamin D.sub.3.Type: GrantFiled: January 12, 1994Date of Patent: March 7, 1995Assignee: Wisconsin Alumni Research FoundationInventors: Hector F. Deluca, Heinrich K. Schnoes
-
Patent number: 5393749Abstract: A method of treating osteoporosis comprising the administration of an effective amount of 1.alpha.,25-dihydroxy-22(E)-dehydro-vitamin D.sub.3.Type: GrantFiled: October 25, 1993Date of Patent: February 28, 1995Assignee: Wisconsin Alumni Research FoundationInventors: Hector F. DeLuca, Heinrich K. Schnoes
-
Patent number: 5362719Abstract: The invention relates to the use of certain vitamin D analogues for the treatment of acne. The analogues have only moderate activity on the calcium metabolism when compared to 1,25-(OH).sub.2 D.sub.3, but retain the ability to activate receptors for 1,25-(OH).sub.2 D.sub.3 not associated with calcium absorption or bone calcium mobilization.Type: GrantFiled: November 24, 1993Date of Patent: November 8, 1994Assignee: Leo Pharmaceutical Products, Ltd. a/s Lovens Kemiske Fabrik Produktionsaktieselskab)Inventor: Wagn Ole Godtfredsen
-
Patent number: 5358720Abstract: A regimented therapeutic method for he alleviation of arthritic conditions by orally administering a selective combination of vitamins and minerals in scheduled dosage amounts. The daily scheduled regiment involves the administration of about 25-100 mg of nicotinic acid three times per day, about 200-1000 mg of calcium ascorbate three times a day, and a single dosage form of a copper-free multivitamin with multiminerals to be taken once a day.Type: GrantFiled: October 22, 1993Date of Patent: October 25, 1994Inventors: Richard M. Koppel, Karl Verebey
-
Patent number: 5350773Abstract: Disclosed are stable liquid products as consisting essentially ofat least one finely dispersed physiologically tolerated fat-soluble substance as disperse phase;glycerol or glycerol mixed with water as continuous phase; andesters of ascorbic acid with long-chain fatty acids as an emulsifier and stabilizer.Type: GrantFiled: January 8, 1993Date of Patent: September 27, 1994Assignee: BASF AktiengesellschaftInventors: Loni Schweikert, Clemens Sambale
-
Patent number: 5350745Abstract: Method of increasing the strength of contraction in the mammalian heart muscle by administering to the mammal an effective amount of an activated Vitamin D compound, i.e. a 1.alpha.-hydroxylated Vitamin D compound which binds with the Vitamin D receptor and produces a positive inotropic effect in the heart muscle. The activated Vitamin D compound may be given as a means to treat myocardial failure.Type: GrantFiled: January 29, 1993Date of Patent: September 27, 1994Assignee: Lunar CorporationInventors: Carl E. Gulbrandsen, Richard L. Moss
-
Patent number: 5332579Abstract: A nutritional supplement, functioning as a food for special dietary use, enhances diets and assists persons recovering from addiction to health damaging substances. Since cellular damage and deficiencies occur and continue to exist even after the person has stopped abusing the substances, use of the nutritional supplement, which contains a variety of minerals, vitamins, herbs, amino acids, and other substances and nutrients, should be continuous. The nutritional supplement consists of a mixture of nutrients which cooperate synergistically in enhancing cellular metabolic pathways and assists in normalization of cellular functions and optimization of cellular health.Type: GrantFiled: November 20, 1992Date of Patent: July 26, 1994Inventor: Anthony J. Umbdenstock
-
Patent number: 5328903Abstract: A composition for solid pharmaceutical preparations containing a vitamin D.sub.3 derivative capable of permitting the derivative to be uniformly distributed in the composition while being stabilized. The composition contains an excipient consisting of mannitol and sugar, a degradative agent consisting of hydroxypropyl cellulose, and a binder consisting of polyvinyl pyrrolidone and hydroxypropylmethyl cellulose.Type: GrantFiled: February 10, 1993Date of Patent: July 12, 1994Assignees: Taisho Pharmaceutical Co. Ltd., Sumitomo Pharmaceuticals Co. Ltd., Wisconsin Alumni Research FoundationInventors: Kuniaki Ishii, Yumiko Toriumi, Shigeru Itai, Hidefumi Hayashi, Masami Nemoto
-
Patent number: 5321018Abstract: A novel use for 1.alpha.-hydroxylated-19-nor-vitamin D compounds to treat psoriasis inasmuch as these compounds when administered to humans are converted to a metabolite, such as a 1.alpha.,25-dihydroxylated compound, which metabolite in vitro will cause differentiation in a human cell line.Type: GrantFiled: November 20, 1992Date of Patent: June 14, 1994Assignee: Wisconsin Alumni Research FoundationInventor: Hector F. DeLuca
-
Patent number: 5308627Abstract: A nutritional supplement, functioning as a food for special dietary use, enhances diets and assists persons recovering from addiction to health damaging substance(s). Since cellular damage and deficiencies occur and continue to exist even after the person has stopped abusing the substance(s), use of the nutritional supplement, which contains at least one enzyme activating substance and at least one enzyme cofactor, should be continuous. The nutritional supplement consists of a mixture of nutrients which cooperate synergistically in enhancing cellular metabolic pathways and assists in normalization of cellular functions and optimization of cellular health.Type: GrantFiled: November 19, 1992Date of Patent: May 3, 1994Inventor: Anthony J. Umbdenstock, Jr.
-
Patent number: 5292729Abstract: Vitamin and mineral absorption in warm-blooded animals is promoted by means of a class of vitamin chelates where at least one of the bonds between the metal ion and the vitamin ligand is formed between the ion and an electron rich .pi.-cloud of an aromatic ring of the water soluble vitamin. The chelate, containing a total of from one to three ligands, may contain from one up to three vitamin ligands which form a .pi.-bond with the mineral and, when present, one or two amino acid, dipeptide or tripeptide ligands. The mineral is selected from the group consisting of Fe, Cu, Zn, Mg, Mn and Ca. The water soluble vitamin ligand is preferably a residue of nicotinamide, nicotinic acid, pyridoxine, thiamine, riboflavin and folic acid. The amino acid may be any of the naturally occurring .alpha.-amino acids such as glycine. The .pi.-bond vitamin chelates are absorbed more readily from both the gastric and intestinal areas of the GI tract than vitamins or minerals administered separately or as mixtures.Type: GrantFiled: August 14, 1992Date of Patent: March 8, 1994Assignee: Albion International, Inc.Inventor: Harvey H. Ashmead